How long to live with a malignant tumor of the right kidney can not be generalized, according to the clinical stage of the malignant tumor, pathological type, physical condition, treatment effect and other factors to determine the survival period. Clinically, “five-year survival rate” is commonly used to assess the survival of tumor patients. The five-year survival rate of patients with stage I, II, III and IV kidney cancer can reach 92%, 86%, 64% and 23% respectively after treatment. Generally speaking, the earlier the disease is detected, diagnosed and treated, the less the disease will affect the life expectancy, and it is recommended to have regular treatment as early as possible. It should be noted that kidney cancer can be improved through “early detection, early diagnosis and early treatment” to reduce the adverse effects of the disease, and it is recommended to receive regular treatment as soon as possible.